GentiBio
Nicole is an Associate Scientist on the Genti Discovery Team at GentiBio. Prior to joining GentiBio, Nicole worked on the oncology in vivo pharmacology team at Biocytogen where she discovered her passion for in vivo science. After traveling to the U.S., Nicole earned her BS in Neuropsychology at UNH.
This person is not in any offices
GentiBio
GentiBio, Inc., is an early stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory and allergic diseases. GentiBio's proprietary autologous and allogeneic EngTregs platform integrates key complimentary technologies needed to successfully restore immune tolerance and overcome major limitations in existing regulatory T-cell therapeutics. GentiBio is at the forefront of leveraging a unique therapeutic modality that can be used to address the fundamental cause of many diseases that result from overshooting and/or malfunctioning of the immune system.